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Objectives. The purpose of this study was to determine the
effects of sodium channel blockade on anisotropic excitation
propagation in the intact canine left ventricle.
Background. Anisotropic ventricular conduction—electric con-
ductivity dependent on the myocardial fiber direction—is one of
the important mechanisms of ventricular arrhythmia. However,
the effects of sodium channel blockade, especially the differential
effect of a subclass of this agent, on the anisotropic properties
remain unknown.
Methods. In 28 anesthetized, open chest dogs, a small cannula
was inserted into the left anterior descending coronary artery.
Saline (control), disopyramide, lidocaine or flecainide was infused
selectively into the cannula. An array of 64 epicardial electrodes
was placed on the anterior surface of the ventricle. Activation time
(AT) was measured along the longitudinal (L) and transverse (T)
directions.
Results. High dose flecainide (100 mg/kg body weight per min)
delayed the AT along the L direction markedly (mean [6SE]
227 6 38%, p < 0.02) and mildly (121 6 10%, p < 0.02) along the
T direction in regular beats (p < 0.007, L vs. T). Lidocaine and
disopyramide did not show direction-dependent prolongation of
the AT on regular beats. When examined on premature beats, AT
was delayed, depending on the coupling interval and the fiber
direction when saline, flecainide or lidocaine was infused. The
conduction blocks along the L direction were observed in three of
seven dogs on regular beats after flecainide and ventricular
fibrillation ensued in two of these three dogs.
Conclusions. A peculiar slowing of L conduction by flecainide
may relate to the character of proarrhythmia.
(J Am Coll Cardiol 1997;29:1639–44)
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Excitation conduction on the myocardium is dependent on
myocardial fiber direction (1–5), which is known as “aniso-
tropy.” Anisotropic properties of cardiac muscle cause block of
an electric excitation owing to a reduced safety factor for
conduction along with longitudinal (L) fiber orientation, al-
though conduction velocity is faster (2,3). Such conduction
block contributes to the induction of reentrant activity as a
component of the reentry circuit (2,3).
Sodium channel blockade suppresses electric conductivity
and is used to block the reentrant circuit as a class I antiar-
rhythmic agent. The class I agent was traditionally subclassified
into Ia, Ib and Ic, mainly depending on the action potential
duration (APD) (6). Recently, heterogeneity of class I agents
was emphasized on use dependency and state dependency
(activation or inactivation) on sodium blocking action (7–9).
Such heterogeneity in sodium channel blockade possibly af-
fects anisotropic electric propagation. Nevertheless, the effect
of each subclass of sodium channel blockers on anisotropism
remains unknown. The purpose of this study was to evaluate
the directional differences in ventricular conduction caused by
sodium channel blockade. We examine the effects of disopyr-
amide, lidocaine and flecainide on both L and transverse (T)
electric propagation.
Methods
Surgical preparation. Twenty-eight adult mongrel dogs
were anesthetized with sodium pentobarbital (30 mg/kg intra-
venously), intubated and ventilated by a respirator with room
air supplemented with oxygen (3 to 5 liters/min). The thorax
was opened in the fifth intercostal space; the pericardium was
opened; and a pericardial cradle was made to support the heart
at an appropriate position. The chest cavity was covered with
plastic wrap to prevent cooling or dehydration. The body
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temperature was maintained at 37 to 38°C. An arterial line was
inserted into the right femoral artery to continuously monitor
the mean arterial pressure. Another polyvinyl catheter was
inserted into the left ventricular cavity to measure left ventric-
ular pressure. Lead II of the electrocardiogram as well as blood
pressure was recorded simultaneously throughout the study
(NEC Sanei, model 2G66, Tokyo, Japan).
A 24-gauge plastic cannula was inserted into the left
anterior descending coronary artery (LAD) at the distal site of
the second diagonal branch (Fig. 1). Heparin (10,000 IU) was
intravenously administered before the LAD cannulation. The
cannula was kept open by continuous infusion of saline in
1 ml/min.
Electrodes for recording and pacing. An array of 64 unipo-
lar electrodes (;14 3 14 mm) was placed on the anterior
surface of the left ventricle (Fig. 1). Each electrode was made
of fine silver wires (0.005-in. [0.013-cm] diameter) and was
insulated, except at the point of attachment. All recordings
were referenced to the Wilson central terminal, and multichan-
nel electrograms were digitized every millisecond using a
multichannel data processing system (CD-G015, Chunichi
Denshi, Nagoya, Japan), as described in a previous study (10).
Formalin was injected into the atrioventricular conduction
system, according to a previously described method, to inter-
rupt atrioventricular conduction (11). Electric stimulation of
2-ms current pulses with twice the voltage of the threshold
potential (model 8EN-7203, Nihon Koden, Tokyo, Japan) was
applied to a bipolar electrode fixed at the corner of the array.
Activation time (AT) was defined as the time instant of the
minimal derivative of the local electric potentials (2). Activa-
tion time maps with 2-ms of isochronism were constructed for
each activation array using the computerized devise, where the
time zero was taken at the pacing artifact. The presence of
conduction block was defined as a slowing of the conduction
velocity ,0.05 m/s between adjacent electrode sites. The
percent difference of AT was calculated from the beat of the
baseline measurement in protocol 1 or from the regular basic
beat in protocol 2. The AT on lead A8 was used to assess the
L conduction, and those on lead H1 the T conduction.
Experimental protocol. Protocol 1: examination on basal
regular beats. Physiologic salt solution (saline; n 5 7), disopyr-
amide (low dose: 20 mg/kg body weight per min; high dose:
200 mg/kg per min; n 5 7), lidocaine (low dose: 0.12 mg/kg per
min; high dose: 0.6 mg/kg per min; n 5 7) or flecainide (low
dose: 10 mg/kg per min; high dose: 100 mg/kg per min; n 5 7)
was intracoronarily infused. A lower dose of disopyramide,
lidocaine or flecainide was almost 1% of that used intrave-
nously in experimental studies (12–14), and a higher dose was
5% to 10%. After the baseline measurement, the low dose
infusion was loaded during the first 20 min, and the high dose
infusion was continued for the next 20 min. The heart was
paced at a basic cycle length of 500 ms. Sixty-four epicardial
electrograms were simultaneously recorded every 5 min. When
spontaneous ventricular tachyarrhythmias occurred, the elec-
trograms were also recorded.
Protocol 2: effect of coupling interval on anisotropic conduc-
tion. After the heart was paced by a basic cycle length of
500 ms for 1 min or longer, a single extrastimulus was applied
on the same pacing site. The coupling interval of the extra-
stimuli was 300, 240, 220, 200, 195, 190 and 185 ms, if
applicable, and 64 epicardial electrograms were simultaneously
recorded during the stimulation. These procedures are re-
peated after loading the low dose of disopyramide, lidocaine,
flecainide or saline.
Statistical analysis. Data are presented as mean value 6
SE. Comparisons of dose-dependent or coupling interval–
dependent changes in ATs were made by using analysis of
variance for repeated measures and the Wilcoxon signed-rank
test. Comparisons of ATs between L and T conduction or
among the three types of sodium channel blockers and saline
infusion were performed by analysis of variance, followed by
the Sheffe´ test. Differences were considered significant at p ,
0.05.
Results
Twenty-eight dogs were studied: seven were given disopy-
amide, seven lidocaine, seven flecainide and seven saline. No
Abbreviations and Acronyms
APD 5 action potential duration
AT 5 activation time
L 5 longitudinal
LAD 5 left anterior descending coronary artery
T 5 transverse
VF 5 ventricular fibrillation
Figure 1. An experimental model. A 64-electrode array is placed on
the anterior epicardial surface of the left ventricle. Columns (A to H)
and rows (1 to 8) of the epicardial electrodes are 2 mm apart. A small
cannula is inserted into the distal LAD as a route of drug administra-
tion. AO 5 aorta; IVC 5 inferior vena cava; L 5 longitudinal
propagation; LV 5 left ventricle; PA 5 pulmonary artery; RA 5 right
atrium; RV 5 right ventricle; SVC 5 superior vena cava; T 5
transverse propagation.
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significant changes in arterial pressure, left ventricular systolic
pressure and left ventricular end-diastolic pressure were ob-
served before and after each sodium channel blocker or saline
infusion (Table 1).
Conduction block and ventricular fibrillation. Figure 2,
upper panel, shows isochronal maps of ATs before and after
intracoronary infusion of flecainide in low and high doses.
Ventricular pacing at a basic cycle length of 500 ms was
performed at the site indicated by an asterisk. Propagation of
excitation was faster in the L direction than in the T direction.
Mean conduction velocity at the basal state was 0.55 6 0.04 m/s
in L conduction and 0.22 6 0.02 m/s in T conduction (p , 0.01,
L vs. T). After flecainide infusion, line density shown in
isochronal maps increased mainly along the L axis, which was
further exaggerated in a high dose. Slowed conduction area
appeared mostly along the L direction, as shown in Figure 2A.
In the case of Figure 2B, a conduction block was noted along
the L direction between rows 6 and 7 after a high dose of
flecainide. Such conduction block occurred in three of the 28
dogs. All three events were observed in a high dose of
flecainide. The site of conduction block was always along the L
direction. The area of conduction block gradually expanded,
and ventricular fibrillation (VF) ensued (Fig. 2B, lower panel).
In two of these three dogs, VF evolved, although VF did not
occur in the other 25 dogs in which the conduction block did
not appear.
Anisotropic effects of sodium channel blockers in basal
regular beats. The percent changes in ATs after intracoronary
infusion of saline or sodium channel blockers were summa-
rized in the L and T directions (Fig. 3). Dogs developing
conduction block were excluded from this calculation. The
number of excluded dogs was one for 30-min through 40-min
measurements and two for the 40-min measurement during
flecainide loading. After flecainide infusion, ATs were delayed
along the L direction mildly (122 6 10%, p , 0.02 vs. baseline)
by a low dose and remarkably (227 6 38%, p , 0.02 vs.
baseline) by a high dose. In contrast, ATs along the T direction
did not change by a low dose but were mildly delayed (121 6
10%, p , 0.05 vs. baseline) by a high dose. Lidocaine infusion
also mildly delayed electric propagation similarly along the L
direction (122 6 12%, p , 0.05 vs. baseline) and T direction
(117 6 8%, p , 0.05 vs. baseline). However, there were no
significant differences in the degree of suppression between the
L and T directions with lidocaine loading. Disopyramide
infusion or saline did not affect ATs in either direction.
Table 1. Effects of Saline and Each Sodium Channel Blocker on Left Ventricular Pressure and
Aortic Pressure
LV Pressure (mm Hg)
Ao Pressure (mm Hg)Systolic End-Diastolic
Before
After
Before
After
Before
After
Low
Dose
High
Dose
Low
Dose
High
Dose
Low
Dose
High
Dose
Saline 110 6 20 115 6 24 113 6 20 8 6 9 8 6 7 6 6 9 95 6 22 97 6 26 94 6 28
Disopyramide 113 6 23 110 6 21 109 6 25 8 6 8 9 6 8 9 6 7 94 6 20 92 6 22 93 6 27
Lidocaine 112 6 18 108 6 24 105 6 25 8 6 7 8 6 9 7 6 9 91 6 27 88 6 23 87 6 28
Flecainide 120 6 26 116 6 28 113 6 24 5 6 6 6 6 7 5 6 6 98 6 24 92 6 24 94 6 27
Data presented are mean value 6 SD. Ao 5 aortic; LV 5 left ventricular.
Figure 2. Isochronal maps of AT before and after intracoronary infusion
of flecainide. An asterisk indicates the site of electric stimulation. The
pacing cycle length was 500 ms. Isochrones at 2-ms intervals were drawn
by a computer program by linear interpolation of ATs. On each map, a
low density in isochronal lines indicates high conduction velocity, and a
high density in the lines indicates low conduction velocity. A, A represen-
tative dog developed slowed conduction along the L direction. B, A
representative dog developed conduction block. In the latter case, spon-
taneous ventricular tacharrhythmias (lower panel) occurred. In the “beat
a,” an enlargement of the conduction block area was seen. L 5 longitu-
dinal propagation; T 5 transverse propagation.
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Mean conduction velocities after high dose loading were
0.24 6 0.03 m/s (p , 0.02 vs. baseline) along L and 0.19 6 0.03
m/s (p , 0.02 vs. baseline) along T with flecainide; 0.45 6 0.04
m/s (p , 0.05 vs. baseline) along L and 0.19 6 0.02 m/s (p ,
0.05 vs. baseline) along T with lidocaine; and 0.50 6 0.04 m/s
along L and 0.22 6 0.02 m/s along T with disopyramide.
Coupling interval–dependent suppression of anisotropic
conduction. Effects of coupling intervals on anisotropic con-
duction were examined on the premature beats (Fig. 4). In the
control state (saline infusion), delays in ATs were significant at
a coupling interval #200 ms in both fiber directions. With
flecainide loading, ATs along the L conduction were markedly
delayed at a coupling interval #195 ms compared with ATs
along the L conduction in the control state, as well as at a
coupling interval #190 ms compared with ATs along the T
conduction in flecainide loading. The same tendency was
observed on the anisotropic conduction on the premature
beats after loading with lidocaine. The differences in ATs
between L and T conduction were statistically significant at a
coupling interval #220 ms. With disopyramide loading, the
premature stimuli failed at a coupling interval #220 ms
because it prolonged the relative refractory period. Conduc-
tion suppression was subtle in cases of disopyramide infusion.
Discussion
Experimental design. The effects of sodium channel block-
ade on anisotropic conduction remain debated. Several inves-
tigators reported a lack of different effects of sodium channel
blockade between L and T conduction (15–17). It was also
suggested that only toxic doses of the class Ic agent could cause
such different effects (18). Such controversies depend partly on
the route of drug administration—intravenous or intracoro-
nary. In the present study, the effects of sodium channel
blockade, especially those of each subclass on the anisotropic
properties of ventricular conduction, were examined on the
epicardial surface of the canine ventricle. Agents were infused
selectively into the distal portion of the LAD, and a multiple
electrode array was applied to measure regional ATs parallel
or perpendicular to the myocardial fiber orientation. The left
ventricular epicardial surface is appropriate for the present
study because the myocardial fiber orientation is visible and
the ventricular myocardium predominates the electric excita-
tion owing to anatomic remoteness from the conduction
system.
We used AT as a marker of ventricular conduction.
Changes in AT were evaluated by calculating percent changes.
This variable permits us to estimate the degree of changes in
conduction, even when it includes artifacts such as virtual
cathode effects (19). In this study, we defined the presence of
conduction block as a conduction velocity ,0.05 m/s. The
reason we used this value is that it is just below the reported
minimal conduction velocity (20).
Basal regular beats. In the present study, ventricular con-
duction was suppressed mainly by flecainide along the direc-
tion of L fibers. Its effect was mild (112 6 10%) in a low dose
and remarkable (227 6 38%) in a high dose. Lidocaine and
disopyramide did not show the conspicuous suppression when
it was examined on the basal regular beats. It has been
reported that conduction parallel to the L fiber direction is
fragile, although the conduction velocity is faster (1,2). The
conduction disturbance or block, especially along the L direc-
Figure 3. Effects of saline, disopyramide, lidocaine and flecainide on
the AT (percent from baseline) in L and T propagation with low and
high doses. The dogs developing conduction block were excluded from
this calculation. *p , 0.05 and **p , 0.01, L versus T (by the Scheffe´
test). #p , 0.05 versus baseline (by Wilcoxon signed-rank test). Data
are expressed as mean value 6 SE.
Figure 4. Effects of shortening coupling interval (CI) on AT (percent
from 500 ms) in L and T propagation with saline, flecainide, lidocaine
and disopyramide. #p , 0.05 and ##p , 0.01, L versus T (by the
Scheffe´ test). Data are expressed as mean value 6 SE.
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tion, ensued after loading sodium channel blockers on the
myocardium. The directional difference in conduction is ex-
plained by effective membrane capacitance and effective axial
resistivity. Spach et al. (20) demonstrated that the relatively
high membrane capacitance and low axial resistivity along the
L direction was a producer of fragile conduction of this
direction.
It is noteworthy that only flecainide slowed the directional
difference on conduction at both high and low doses, whereas
the other sodium channel blockers did not show such differ-
ences in both doses at regular basic beats. Doses of sodium
channel blocker were determined by referencing reported
experimental studies of intravenous use in dogs or rabbits. We
supposed that these doses might be higher than those in
therapeutic use in humans, even in low doses. This result
cannot directly extend to clinical use of those agents. However,
the present study provided evidence that only flecainide po-
tentially causes a peculiar slowing of L conduction in regular
beats.
One possible explanation for this phenomenon is the dif-
ferences in unbinding from the sodium channel among sodium
channel blockers. The recovery time constant of flecainide was
reported to be 15.5 s (21), and it was classified as a slow kinetic
drug. In contrast, that of lidocaine was only 0.23 s (21), and it
was classified as a fast kinetic drug. Because the cycle length of
regular beats was 500 ms, binded lidocaine is removed from the
sodium channel by the next beat. Consequently, the sodium
channel blocking effect of flecainide would be remarkably
greater than that of lidocaine. Another possible explanation is
an open-state blocking action of flecainide (9). The open time
of sodium channels is prolonged more along the L propagation
than the T propagation (20). Conduction suppression by
open-state sodium channel blockade should be more promi-
nent along the L propagation than the T propagation. How-
ever, these may not fully explain the effects of disopyramide,
which was classified as an intermediate kinetic and open-state
blocking drug (8,9). To clarify the mechanisms of anisotropic
effects of sodium channel blockers, further examination will be
needed.
Coupling interval–dependent action. Premature depolar-
ization is characterized by a markedly depressed V˙max (i.e.,
weak inward current). However, a coupling interval depen-
dency of the effects of sodium channel blockade on the
coupling intervals was not fully examined. In the present study,
it is hypothesized that the sodium channel blockade suppresses
L propagation more prominently than T propagation, because
L propagation is already fragile (1,2). When the coupling
interval of the premature beats became shorter than 240 ms,
ATs were delayed in the saline group and even more delayed
after flecainide or lidocaine loading. The conduction parallel
to the L fiber orientation was depressed more than that of the
T orientation.
The effects of lodocaine on anisotropic conduction became
apparent when a coupling interval was short. This action of
lidocaine suggests that the use dependency may be a central
mechanism. Lidocaine has a short recovery time constant.
Therefore, lidocaine slowed conduction anisotropically only
when the coupling interval was enough short. In contrast,
disopyramide did not show such apparent suppression. This is
because prolongation of refractory periods by disopyramide
causes a failure of premature stimuli at short coupling inter-
vals.
New, unexpected effect of flecainide: spontaneous induction
of VF on intact myocardium. Anisotropic properties in exci-
tation propagation are known as one of the important mech-
anisms of arrhythmia (1–3,5,22). The action of sodium channel
blockers, as a factor that augments the anisotropic nature, is
sometimes proarrhythmic. The present experiment showed
first that flecainide itself causes VF in the intact myocardium.
The proarrhythmic effects of flecainide has been reported in
the subacute phase of infarct (3 to 5 days after ligation) in dogs,
in which reentrant ventricular arrhythmia was easily inducible
(15,16,23). Usui et al. (23) measured the VF threshold by a
train stimulus and concluded that flecainide dose dependently
decreased the fibrillation threshold in the intact myocardium
(23). However, no reports have described the induction of
spontaneous VF by sodium channel blockers in the intact
myocardium. Surprisingly, after flecainide infusion into the
coronary artery, VF spontaneously occurred. The fact that
block of the L propagation preceded the arrhythmia suggests
that the mechanism of this arrhythmia is “anisotropic reentry.”
We suppose that this type of agent should be carefully selected
for clinical use even if there is no additional abnormal condi-
tion, such as ischemia or heart failure.
Conclusions. Flecainide caused a peculiar slowing and
block of the L conduction in regular beats of the intact
myocardium. This conduction block was related to the spon-
taneous induction of VF. “Anisotropic reentry” may be one of
the important mechanisms of proarrhythmia in sodium chan-
nel blockade, especially with flecainide.
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